Blood Test for Alzheimer’s on the Horizon: ALZpath Licenses pTau217 Antibody to Roche
What You Should Know:
– ALZpath, a leader in Alzheimer’s disease diagnostics, announced a licensing agreement with Roche for their innovative pTau217 antibody. This paves the way for a blood test to diagnose Alzheimer’s disease…
Continue Reading